Literature DB >> 17728781

Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine.

S Henrich, R I Christopherson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728781     DOI: 10.1038/sj.leu.2404929

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro.

Authors:  Sarah Weiler; Jolaolu A Ademokun; John D Norton
Journal:  Mol Cancer       Date:  2015-02-03       Impact factor: 27.401

2.  The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia.

Authors:  Kimberley L Kaufman; Yiping Jenkins; Munther Alomari; Mehdi Mirzaei; O Giles Best; Dana Pascovici; Swetlana Mactier; Stephen P Mulligan; Paul A Haynes; Richard I Christopherson
Journal:  Oncotarget       Date:  2015-12-01

3.  EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine.

Authors:  Roberta Valsecchi; Nadia Coltella; Daniela Magliulo; Lucia Bongiovanni; Lydia Scarfò; Paolo Ghia; Maurilio Ponzoni; Rosa Bernardi
Journal:  Open Biol       Date:  2020-05-13       Impact factor: 6.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.